Haleon: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Alex Neman (bicara | kontrib) kTidak ada ringkasan suntingan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
(27 revisi perantara oleh 7 pengguna tidak ditampilkan) | |||
Baris 1:
{{Expand language|topic=|langcode=en|otherarticle=Haleon|date=November 2024}}
{{Kembangkan|date=November 2024}}
{{Infobox company
| name = Haleon plc
Baris 9 ⟶ 12:
| traded_as = {{ubl|{{lse|HLN}}|{{nyse|HLN}}|[[FTSE 100]] component}}
| ISIN = GB00BMX86B70
| predecessor = GSK Consumer Healthcare<br/>Pfizer Consumer Healthcare
| area_served = Seluruh dunia
| key_people = {{plainlist|
Baris 16 ⟶ 19:
}}
| industry = {{ubl|[[Farmasi]]|[[Barang konsumen yang bergerak cepat|Barang konsumen]]}}
| products = {{hlist|[[Higiene mulut]]
| brands = {{flatlist|
* [[Actifed]]
Baris 26 ⟶ 29:
* [[Caltrate]]
* [[Centrum (multivitamin)|Centrum]]
* Contac
* [[Emergen-C]]
Baris 48 ⟶ 50:
* [[Diclofenac|Voltaren]]
}}
| revenue ={{increase}} £10,858 juta (2022)<ref name="results">{{cite web
| operating_income = {{increase}} £1,825 million (2022)<ref name="results"/>
| net_income ={{decrease}} £1,119 juta (2022)<ref name="results"/>
| assets ={{increase}} £34,815 juta (2022)<ref name="results"/>
| equity ={{decrease}} £16,457 juta (2022)<ref name="results"/>
| num_employees = 22,000+ (2022)<ref>{{cite news |url=https://www.theguardian.com/business/2022/jul/18/gsk-haleon-begins-trading-listing-shares-market-value |title=GSK spin-off Haleon begins trading in biggest European listing in a decade |date=18 Juli 2022 |work=[[The Guardian]] |first1=Mark |last1=Sweney |first2=Julia |last2=Kollewe |access-date=2023-08-12 |archive-date=2023-02-02 |archive-url=https://web.archive.org/web/20230202160535/https://www.theguardian.com/business/2022/jul/18/gsk-haleon-begins-trading-listing-shares-market-value |dead-url=no }}</ref>
| owners = {{plainlist|
* [[Pfizer]] (32%)
Baris 65 ⟶ 67:
}}
'''Haleon plc''' adalah perusahaan kesehatan konsumen multinasional Inggris dengan kantor pusat di [[Weybridge]], [[Inggris]].<ref>{{Cite web|title=GSK announces independent Consumer Healthcare company is to be called Haleon {{!}} GSK|url=https://www.gsk.com/en-gb/media/press-releases/gsk-announces-independent-consumer-healthcare-company-is-to-be-called-haleon/|website=www.gsk.com|language=en-GB|access-date=21 Februari 2023|archive-date=2023-02-21|archive-url=https://web.archive.org/web/20230221203149/https://www.gsk.com/en-gb/media/press-releases/gsk-announces-independent-consumer-healthcare-company-is-to-be-called-haleon/|dead-url=no}}</ref> Perusahaan ini adalah salah satu bisnis perawatan kesehatan konsumen terbesar di dunia, dengan merek termasuk [[pasta gigi]] [[Sensodyne]], [[Analgesik|obat penghilang rasa sakit]] [[Parasetamol|Panadol]] dan [[Ibuprofen|Advil]] serta [[vitamin]] [[Centrum (multivitamin)|Centrum]].<ref>{{Cite news|last=Ralph|first=Alex|date=2 Juli 2022|title=GlaxoSmithKline prepares to get back to basics with historic break-up|url=https://www.thetimes.co.uk/article/three-centuries-of-gsk-story-about-to-add-a-new-chapter-3jrbn8kkq|work=[[The Times]]|access-date=4 Juli 2022|archive-date=2023-08-05|archive-url=https://web.archive.org/web/20230805105647/https://www.thetimes.co.uk/article/three-centuries-of-gsk-story-about-to-add-a-new-chapter-3jrbn8kkq|dead-url=no}}</ref> Perusahaan ini adalah pemimpin global dalam obat [[Penggolongan Obat|bebas]] dengan pangsa pasar 7,3 persen.<ref name="forbes1">{{Cite news|last=Cornell|first=Joe|date=15 Juli 2021|title=GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022|url=https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|work=[[Forbes]]|access-date=10 Juni 2022|archive-date=2023-02-11|archive-url=https://web.archive.org/web/20230211180517/https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|dead-url=no}}</ref>
Haleon didirikan pada 18 Juli 2022 sebagai pemisahan perusahaan dari [[GSK plc|GSK]].<ref>{{Cite web|title=Prospectus|url=https://www.gsk.com/media/7702/haleon-plc-prospectus.pdf|publisher=GSK plc|page=15|access-date=10 Juni 2022|archive-date=2022-06-01|archive-url=https://web.archive.org/web/20220601125715/https://www.gsk.com/media/7702/haleon-plc-prospectus.pdf|dead-url=yes}}</ref>
Sir [[Dave Lewis (pengusaha)|David Lewis]] adalah [[ketua]], dengan Brian McNamara sebagai CEO.<ref name="haleonsky">{{Cite news|last=Kleinman|first=Mark|date=3 Mei 2022|title=GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks|url=https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875|work=[[Sky News]]|access-date=10 Juni 2022|archive-date=2023-02-11|archive-url=https://web.archive.org/web/20230211180519/https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875|dead-url=no}}</ref> Haleon terdaftar di [[Bursa Efek London|London Stock Exchange]] dan merupakan komponen dari [[Indeks FTSE 100|FTSE 100]], dengan listing sekunder di [[Bursa Efek New York|New York Stock Exchange]]. Penjualan tahunan berjumlah sekitar £10 miliar di 120 pasar pada tahun 2020.<ref name="forbes12">{{Cite news|last=Cornell|first=Joe|date=15 July 2021|title=GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022|url=https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|work=[[Forbes]]|access-date=10 Juni 2022|archive-date=2023-02-11|archive-url=https://web.archive.org/web/20230211180517/https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|dead-url=no}}</ref>
Di Indonesia, Haleon beroperasi di bawah dua perusahaan yaitu '''PT Sterling Products Indonesia''' yang mengemas dan merilis Panadol serta Scott's Emulsion, dan '''PT Haleon Indonesia Trading''' (sebelumnya bernama '''PT GSK Consumer Healthcare Indonesia''') yang mendistribusikan Sensodyne serta Polident.
== Sejarah ==
GSK dan [[Pfizer]] menggabungkan bisnis layanan kesehatan konsumen mereka pada tahun 2019.<ref name="cnn1">{{Cite news|last=Shane|first=Daniel|date=19 Desember 2018|title=Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses|url=https://edition.cnn.com/2018/12/19/business/pfizer-gsk-healthcare/index.html|work=[[CNN]]|access-date=10 Juni 2022|archive-date=2023-06-06|archive-url=https://web.archive.org/web/20230606095307/https://edition.cnn.com/2018/12/19/business/pfizer-gsk-healthcare/index.html|dead-url=no}}</ref> GSK memiliki lebih dari dua pertiga dari [[Perusahaan patungan|usaha patungan tersebut]], dan Pfizer memegang sisanya.<ref name="cnn1" />
GSK mengumumkan rencana untuk memisahkan Haleon pada tahun 2018, untuk memberikan "fokus ekstra dan daya tembak ekstra kepada pembuat obat yang lelah dengan mempersiapkan dan menghentikan divisi konsumen".<ref name="reuters1">{{Cite news|last=Donnellan|first=Aimee|date=9 Juni 2022|title=GSK castoff starts life with target on its back|url=https://www.reuters.com/breakingviews/gsk-castoff-starts-life-with-target-its-back-2022-06-09/|work=[[Reuters]]|access-date=10 Juni 2022|archive-date=2022-09-22|archive-url=https://web.archive.org/web/20220922114359/https://www.reuters.com/breakingviews/gsk-castoff-starts-life-with-target-its-back-2022-06-09/|dead-url=no}}</ref>
[[Unilever]] menawarkan £50 miliar untuk bisnis tersebut pada tahun 2022, dalam tawaran yang ditolak GSK.<ref name="guardian1">{{Cite news|last=Jolly|first=Jasper|date=19 Januari 2022|title=Unilever will not increase £50bn offer for GSK consumer arm|url=https://www.theguardian.com/business/2022/jan/19/unilever-will-not-increase-50bn-offer-for-gsk-consumer-arm|work=[[The Guardian]]|access-date=10 Juni 2022|archive-date=2022-10-18|archive-url=https://web.archive.org/web/20221018002210/https://www.theguardian.com/business/2022/jan/19/unilever-will-not-increase-50bn-offer-for-gsk-consumer-arm|dead-url=no}}</ref> [[Nestlé]] mengkaji kemungkinan penawaran bersama dengan [[Reckitt Benckiser|Reckitt]].<ref name="bloomberg1">{{Cite news|date=25 Mei 2022|title=Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit|url=https://www.bloomberg.com/news/articles/2022-05-25/nestle-eyed-biggest-ever-deal-in-aborted-move-for-gsk-consumer#xj4y7vzkg|work=[[Bloomberg News]]|access-date=10 Juni 2022|archive-date=2023-04-30|archive-url=https://web.archive.org/web/20230430142405/https://www.bloomberg.com/news/articles/2022-05-25/nestle-eyed-biggest-ever-deal-in-aborted-move-for-gsk-consumer#xj4y7vzkg|dead-url=no}}</ref>
Usulan spin-off merek perawatan bibir [[ChapStick]] senilai $600 juta diperdebatkan pada tahun 2023.<ref name="bloomberg2">{{Cite news|last=Tse|first=Crystal|last2=Nair|first2=Dinesh|last3=David|first3=Ruth|date=24 Februari 2023|title=GSK Spinoff Haleon Explores Potential $600 Million Sale of ChapStick Brand|url=https://archive.
== Operasi==
Kesehatan mulut menyumbang 28,5 persen dari pendapatan pada tahun 2021.<ref name="gsk1">{{Cite web|title=Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon|url=https://www.gsk.com/en-gb/media/press-releases/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-haleon/|website=GSK|publisher=GSK|access-date=10 Juni 2022|archive-date=2023-03-29|archive-url=https://web.archive.org/web/20230329162356/https://www.gsk.com/en-gb/media/press-releases/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-haleon/|dead-url=no}}</ref>
Aset kotor berjumlah lebih dari £45 miliar pada 31 Maret 2022.<ref name="gsk12">{{Cite web|title=Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon|url=https://www.gsk.com/en-gb/media/press-releases/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-haleon/|website=GSK|publisher=GSK|access-date=10 Juni 2022|archive-date=2023-03-29|archive-url=https://web.archive.org/web/20230329162356/https://www.gsk.com/en-gb/media/press-releases/update-proposed-demerger-of-the-consumer-healthcare-business-from-gsk-to-form-haleon/|dead-url=no}}</ref>
== Merek ==
{{Multiple image | align = right | direction = horizontal | total_width = 300
Merek meliputi:<ref>{{Cite web|title=Our Consumer Healthcare Brands|url=https://www.haleon.com/our-brands/|publisher=Haleon|access-date=19 Juli 2022}}</ref>▼
| image1 = GSK logo 2014.svg
| image2 = Pfizer.svg
| footer = Logo GSK (kiri, 2014-2022) dan Pfizer (kanan, 2009-2021) sebelum pemisahan bisnis produk perawatan kesehatan konsumen membentuk Haleon
}}
[[Berkas:Panadol.JPG|jmpl|Kemasan lama Panadol, obat [[parasetamol]] yang diproduksi oleh PT Sterling Products Indonesia dibawah lisensi dari GSK (sekarang Haleon)]]
▲Merek meliputi:<ref>{{Cite web|title=Our Consumer Healthcare Brands|url=https://www.haleon.com/our-brands/|publisher=Haleon|access-date=19 Juli 2022|archive-date=2023-08-02|archive-url=https://web.archive.org/web/20230802200854/https://www.haleon.com/our-brands|dead-url=no}}</ref>
* [[Abreva]] (Dokosanol)
Baris 148 ⟶ 158:
* [[Synthol (mouthwash)|Synthol]] (kesehatan mulut)
* Theraflu (Pernafasan)
* Triaminic
* [[Tums|Tum]] (pencernaan)
* Viva (vitamin dan natural), asal: [[Nepal]]
Baris 154 ⟶ 165:
== Kepemilikan ==
Pada 2022, Pfizer memiliki 32 persen saham Haleon, sedangkan GSK mempertahankan 13 persen saham.<ref name="reuters12">{{Cite news|last=Donnellan|first=Aimee|date=9 Juni 2022|title=GSK castoff starts life with target on its back|url=https://www.reuters.com/breakingviews/gsk-castoff-starts-life-with-target-its-back-2022-06-09/|work=[[Reuters]]|access-date=10 Juni 2022|archive-date=2022-09-22|archive-url=https://web.archive.org/web/20220922114359/https://www.reuters.com/breakingviews/gsk-castoff-starts-life-with-target-its-back-2022-06-09/|dead-url=no}}</ref>
== Referensi ==
Baris 170 ⟶ 181:
{{Haleon}}
{{Komponen Indeks FTSE 100}}
{{authority control|state=expanded}}
|